GlaxoSmithKline PLCAdd to My Watchlist

GSK:USNew YorkIndustry: Medical-Drugs
  • 40.84
    Last
  • 0.26  -0.63%
    Today's Change
  • 41.10
    Previous Close
  • Today
     
    37.20
    44.54
    52 Week Low - High
8:04 pm ET 10/20/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding2 billion
Market Cap$100 billion
Return on Equity ttm278.84%
Last Dividend$0.50
Dividend Yield ttm4.96
Relative Dividend Yield benchmark--
Dividend Ex-Date8/9/17
Dividend Pay Date10/12/17
Earnings
EPS: Year Actual ttm--
EPS: Year Est. 12/17 ttm2.223
 
EPS: Quarterly Actual 6/17 --
EPS: Quarterly Est. 9/17 0.64
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-89.21
Company Description
GlaxoSmithKline plc is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
Revenue$28 billion
Net Income$912 million
Total Assets$59 billion
Employees99,827
Web Sitewww.gsk.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!